Lenvatinib acts as the salvage therapy for advanced hepatocellular carcinoma

被引：0
|
作者：
Hsieh, M-C. [1 ]
Su, Y-L. [2 ]
Chen, Y-Y. [2 ]
Liu, C-T. [2 ]
Chen, Y-H. [2 ]
Chiu, T-J. [2 ]
Pei, S-N. [3 ]
Wu, C-C. [4 ]
Rau, K-M. [1 ]
机构：
[1] E DA Canc Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[2] Kaohsiung Chang Gung Mem Hosp, Oncol & Hematol, Kaohsiung, Taiwan
[3] Chiayi Chang Gung Mem Hosp, Oncol & Hematol, Chiayi, Taiwan
[4] Chang Gung Mem Hosp Kaohsiung, Internal Med, Kaohsiung, Taiwan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
182P
引用
收藏
页码：57 / 57
页数：1
相关论文
共 50 条
  • [21] Prognostic Advantages of Individual Additional Interventions After Lenvatinib Therapy in Patients with Advanced Hepatocellular Carcinoma
    Junichi Shindoh
    Yusuke Kawamura
    Masahiro Kobayashi
    Norio Akuta
    Satoshi Okubo
    Masaru Matsumura
    Yoshiyuki Suzuki
    Masaji Hashimoto
    Journal of Gastrointestinal Surgery, 2022, 26 (8) : 1637 - 1646
  • [22] Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma
    Wang, Hung-Wei
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Kao, Jung-Ta
    Hsu, Wei-Fan
    Chen, Hung-Yao
    Chang, Che-Wei
    Huang, Guan-Tarn
    Peng, Cheng-Yuan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (05)
  • [23] Systemic therapy with lenvatinib in advanced hepatocellular carcinoma: what to do in the case of a complete radiologic response?
    Shah, Nikita C.
    Shah, Harsh C.
    Amarapurkar, Anjali D.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (01) : 118 - 119
  • [24] Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
    Ohya, Yuki
    Hayashida, Shintaro
    Tsuji, Akira
    Kuramoto, Kunitaka
    Shibata, Hidekatsu
    Setoyama, Hiroko
    Hayashi, Hironori
    Kuriwaki, Kazumi
    Sasaki, Masato
    Iizaka, Masayoshi
    Nakahara, Osamu
    Inomata, Yukihiro
    SURGICAL CASE REPORTS, 2020, 6 (01)
  • [25] EFFICACY AND SAFETY OF LENVATINIB AS A FIRST- LINE THERAPY IN ELDERLY PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Abe, Toshiaki
    Ohki, Takamasa
    Kondo, Mayuko
    Sato, Koki
    HEPATOLOGY, 2023, 78 : S1835 - S1836
  • [26] Prognostic Advantages of Individual Additional Interventions After Lenvatinib Therapy in Patients with Advanced Hepatocellular Carcinoma
    Shindoh, Junichi
    Kawamura, Yusuke
    Kobayashi, Masahiro
    Akuta, Norio
    Okubo, Satoshi
    Matsumura, Masaru
    Suzuki, Yoshiyuki
    Hashimoto, Masaji
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (08) : 1637 - 1646
  • [27] Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy
    Yuki Ohya
    Shintaro Hayashida
    Akira Tsuji
    Kunitaka Kuramoto
    Hidekatsu Shibata
    Hiroko Setoyama
    Hironori Hayashi
    Kazumi Kuriwaki
    Masato Sasaki
    Masayoshi Iizaka
    Osamu Nakahara
    Yukihiro Inomata
    Surgical Case Reports, 6
  • [28] Application and Resistance Mechanisms of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
    Tao, Meng
    Han, Jing
    Shi, Juanyi
    Liao, Hao
    Wen, Kai
    Wang, Weidong
    Mui, Sintim
    Li, Huoming
    Yan, Yongcong
    Xiao, Zhiyu
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 1069 - 1083
  • [29] Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
    Ikeda, Kenji
    Kudo, Masatoshi
    Kawazoe, Seiji
    Osaki, Yukio
    Ikeda, Masafumi
    Okusaka, Takuji
    Tamai, Toshiyuki
    Suzuki, Takuya
    Hisai, Takashi
    Hayato, Seiichi
    Okita, Kiwamu
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (04) : 512 - 519
  • [30] LENVATINIB FOR PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA REFRACTORY TO TRANSCATHETAL CHEMOEMBOLIZATION
    Komorizono, Yasuji
    Nakashima, Kazuhisa
    Shibatou, Toshihiko
    Sako, Katsumi
    GASTROENTEROLOGY, 2019, 156 (06) : S1312 - S1312
12345